ebook Munafa Stock Market Course + Intraday & FNO calls  

       

526953 announcements Venus Remedi announcements and dividends declared BSE

Venus Remedi Complete list of announcements declared & dividend announcements by Venus Remedi 526953

Venus Remedi 526953 listed on BSE and deals in

Announcements and dividends declared by Venus Remedi 526953

Venus Remedies expands Latin America presence with Argentina nod for antibiotic
Venus Remedies has received approval in Argentina for its antibiotic Ceftriaxone. This marks a significant step in the company's Latin America expansion. Argentina is a key market for critical care therapies. Ceftriaxone is vital for treating serious bac
Announcement as on 07 May 2026

Venus Remedies gets new market authorisations for drugs in Vietnam
Pharma major Venus Remedies has received new marketing authorisations in Vietnam for its drugs Methotrexate, Cefuroxime, and Irinotecan. These approvals expand the company's presence in South Asia's growing pharmaceutical market. This marks 29 active produ
Announcement as on 09 November 2025

Venus Remedies gets GMP approval for pre-filled syringe facility
Indian pharmaceutical company Venus Remedies received a significant approval from the Malaysian authorities. The company's Baddi facility, equipped with advanced robotic technology, met the stringent quality standards for producing pre-filled syringes. Thi
Announcement as on 05 November 2024

Venus Remedies get market authorisations for two cancer drugs from Morocco, Philippines
Venus Remedies Ltd has received marketing authorisations for two key oncology drugs, carboplatin and bortezomib, from Morocco and the Philippines. These approvals are part of the company's strategy to expand its oncology range and meet the growing global d
Announcement as on 30 September 2024

Venus Remedies gets marketing authorisations for three cancer drugs from Ukraine
​​ Saransh Chaudhary, President, Global Critical Care, Venus Remedies, said, "These marketing approvals mark a significant milestone in our global expansion strategy. We are looking forward to introducing the entire range of our oncology products in Uk
Announcement as on 18 March 2024

Announcements by Venus Remedi first page | Next page |

526953 Venus Remedi current price & indicator signals

Moving Averages for Venus Remedi

  • 5Day Average: 1368.24
  • 12Day Average: 1480.28
  • 20Day Average: 1567.11
  • 50Day Average: 1622.98
  • 100Day Average: 1657.54
  • 150Day Average: 1428.84
  • 200Day Average: 1259.31

526953 Indicators & signals

Indicator MACD (12,26,9)

1456.23, 1535.63, -45.15
Indicator MACD is in negative zone

Indicator ADX (14)

25.91, 18.45, 31.37
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 47
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 526953 Venus Remedi are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
29 Thu Oct 2026 1279.25 1266.60 to 1329.90 -3.66% 0.78 times
28 Wed Oct 2026 1327.80 1313.50 to 1390.00 -3.96% 1.95 times
27 Tue Oct 2026 1382.60 1382.50 to 1528.00 -4.99% 3.31 times
26 Mon Oct 2026 1455.25 1393.00 to 1466.00 4.22% 0.52 times
23 Fri Oct 2026 1396.30 1367.20 to 1447.95 -2.98% 0.66 times
22 Thu Oct 2026 1439.15 1437.25 to 1542.00 -4.87% 1.14 times
21 Wed Oct 2026 1512.85 1512.45 to 1600.00 -4.97% 0.54 times
19 Mon Oct 2026 1592.05 1583.20 to 1668.00 -3.07% 0.16 times
16 Fri Oct 2026 1642.40 1570.00 to 1642.40 5% 0.49 times
15 Thu Oct 2026 1564.20 1555.65 to 1597.95 -1.49% 0.85 times
14 Wed Oct 2026 1587.80 1550.05 to 1595.25 0.26% 0.38 times
13 Tue Oct 2026 1583.75 1565.55 to 1639.00 -2.57% 0.29 times

Videos related to: 526953 announcements Venus Remedi announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

526953 announcements Venus Remedi announcements and dividends declared BSE

 

Back to top